Manipal Hospitals Strengthens Robotic Cancer Care with Dr. Surender Dabas Leadership

Manipal Hospitals Expands Robotic Cancer Care

In a significant advancement in cancer treatment, Manipal Hospitals has announced the appointment of Dr. Surender Kumar Dabas, a leading figure in robotic oncology, to enhance cancer care within the Delhi NCR region. With over 22 years in surgical oncology, Dr. Dabas brings a wealth of experience and innovation, having performed more than 30,000 surgeries including over 4,000 robot-assisted procedures. His expertise primarily focuses on complex surgeries for head and neck cancer, thoracic cancer, gynecological malignancies, and several other types of cancer.

This strategic move is aligned with Manipal Hospitals' commitment to providing exceptional medical care to both domestic and international patients. Located in Delhi, Gurugram, and Ghaziabad, the hospitals aim to provide world-class cancer treatment, and Dr. Dabas’s leadership is expected to bolster their status as a leading destination for comprehensive cancer care.

Mr. Pramod Alagharu, the Regional COO of the North-West Cluster, expressed pride in welcoming Dr. Dabas and his team of 150 experts. He stated, “With Dr. Dabas’s specialized skills and experience in managing intricate cancer procedures, we are enhancing our capacity to deliver cutting-edge healthcare.” This welcoming speech underscores the hospital’s dedication to being a preferred choice for oncology, particularly in robot-assisted treatments that have revolutionized surgical procedures.

Dr. Dabas is excited to join one of the largest healthcare networks in India. He acknowledges the significant legacy of Manipal Hospitals in the healthcare landscape and emphasizes his goal to improve cancer treatment with the latest robotic technologies. “Our mission is to enhance surgical efficiency and minimize invasiveness, ultimately improving survivorship and quality of life for our patients,” he stated. By employing advanced technologies, the hospital aims to offer improved outcomes for patients confronting cancer.

Under Dr. Dabas’s stewardship, the Manipal Comprehensive Cancer Centre is expected to establish itself further as a center of excellence. The focus will not only be on advanced clinical protocols but also on a patient-centered approach that incorporates evidence-based treatments across multiple specialties. This multidisciplinary approach will attract an increasing number of international patients seeking high-quality, technology-driven cancer therapies.

The healthcare network is renowned for its commitment to providing quality services, serving over 7 million patients annually. With the recent integration of Medica Synergie hospitals, along with expertise and accreditation that emphasizes excellence in treatment, the network now boasts 38 hospitals across 19 cities, equipped with over 10,500 beds and a dedicated workforce of over 20,500 professionals.

Manipal Hospitals has established an impressive reputation built on safety, care, and innovation. Patients choose this institution not just for its state-of-the-art facilities but also for its commitment to ensuring a compassionate journey through treatment. Dr. Dabas's addition is viewed as a crucial step toward solidifying this commitment and expanding access to advanced medical care.

As the landscape of healthcare continues to evolve, with robotic surgery emerging as a preferred method, Manipal Hospitals is setting the benchmark in cancer treatment. Patient welfare remains at the forefront, ensuring that each individual receives tailored care that meets international standards.

For anyone seeking to inquire further about the treatments available or Dr. Dabas’s role, they are encouraged to reach out via email or phone to the dedicated outreach team.

In conclusion, the appointment of Dr. Surender Kumar Dabas symbolizes a promising future for robotic cancer care in India, further establishing Manipal Hospitals as a leader in the healthcare industry. The integration of advanced technology and experienced professionals in oncology underscores a commitment to superior cancer care and patients' health outcomes.